AIM: To analyze the clinical factors influencing the human vision corrections via the changing of ocular components of human eye in various applications; and to analyze refractive state via a new effective axial leng...AIM: To analyze the clinical factors influencing the human vision corrections via the changing of ocular components of human eye in various applications; and to analyze refractive state via a new effective axial length.METHODS: An effective eye model was introduced by the ocular components of human eye including refractive indexes, surface radius(r1, r2, R1, R2) and thickness(t, T) of the cornea and lens, the anterior chamber depth(S1) and the vitreous length(S2). Gaussian optics was used to calculate the change rate of refractive error per unit amount of ocular components of a human eye(the rate function M). A new criterion of myopia was presented via an effective axial length.RESULTS: For typical corneal and lens power of 42 and 21.9 diopters, the rate function Mj(j=1 to 6) were calculated for a 1% change of r1, r2, R1, R2, t, T(in diopters) M1=+0.485, M2=-0.063, M3=+0.053, M4=+0.091, M5=+0.012, and M6=-0.021 diopters. For 1.0 mm increase of S1 and S2, the rate functions were M7=+1.35, and M8=-2.67 diopter/mm, respectively. These rate functions were used to analyze the clinical outcomes in various applications including laser in situ keratomileusis surgery, corneal cross linking procedure, femtosecond laser surgery and scleral ablation for accommodation.CONCLUSION: Using Gaussian optics, analytic formulas are presented for the change of refractive power due to various ocular parameter changes. These formulas provide useful clinical guidance in refractive surgery and other related procedures.展开更多
BACKGROUND Diabetes is a serious public health concern in China,with 30%of patients developing retinopathy,and diabetic macular edema(DME)having the biggest impact on vision.High blood glucose level can cause retinal ...BACKGROUND Diabetes is a serious public health concern in China,with 30%of patients developing retinopathy,and diabetic macular edema(DME)having the biggest impact on vision.High blood glucose level can cause retinal cell hypoxia,thus promoting vascular endothelial growth factor(VEGF)formation and increasing vascular permeability,which induces DME.Moreover,cell hypoxia can accelerate the rate of apoptosis,which leads to the aging of patients.In severe cases,optic cell apoptosis or retinal fibrosis and permanent blindness may occur.AIM To investigate and compare the efficacy,mechanism,and differences between two anti-VEGF drugs(Compaq and ranibizumab)in DME patients.METHODS Ninety-six patients with DME who attended our hospital from April 2018 to February 2020 were included and randomly divided into two groups(Compaq group and ranibizumab group).The groups received vitreal cavity injections of 0.5 mg Compaq and 0.5 mg ranibizumab,respectively,once a month.The best corrected visual acuity(BCVA),intraocular pressure(IOP),macular retinal thickness(CMT),macular choroidal thickness(SFCT),foveal no perfusion area(FAZ),superficial capillary density,deep capillary density,treatment effect,and adverse reactions were compared before and after treatment and between the two groups.RESULTS Before treatment and 1-mo post-treatment,there was no statistically significant difference in the estimated BCVA in both groups(P>0.05).BCVA decreased in the Compaq group 3 mo after treatment,and the difference was statistically significant(P<0.05).Before treatment,and 1 mo and 3 mo post-treatment,there was no statistically significant difference in the estimated IOP in either group(P>0.05).Before treatment and 1-mo post-treatment,there was no statistically significant difference in the estimated CMT,SFCT,or FAZ in either group(P>0.05).CMT and SFCT values decreased in the Compaq group 3 mo post-treatment,and the difference was statistically significant(P<0.05).Before treatment,and 1 mo and 3 mo post-treatment,there were no statistically significant differences in vascular density in the shallow or deep capillary plexi of the fovea,parafovea,or overall macular area between the two groups(P>0.05).Marked efficient,effective,and invalid rates were 70.83%and 52.08%,27.08%and 39.58%,and 2.08%and 8.33%in the Compaq and ranibizumab groups,respectively.The differences between the two groups were statistically significant(P<0.05).CONCLUSION Anti-VEGF drugs can effectively improve CMT and SFCT,without affecting microcirculation,thus providing an effective and safe treatment for patients with DME.展开更多
Aiming at the correction of high-order aberrations of human eye with spectacles, a design method of aspheric spectacles is proposed based on the eye's wavefront aberrations data. Regarding the eyeball and the spec...Aiming at the correction of high-order aberrations of human eye with spectacles, a design method of aspheric spectacles is proposed based on the eye's wavefront aberrations data. Regarding the eyeball and the spectacles as a whole system-the lens-eye system-the surface profiles of the spectacles are achieved by optimization procedure of lens design. Different from the conventional optometry, in which the refraction prescription is acquired with a visual chart, the design takes into account the two aspects of actual human viewing, eyeball rolling and certain distinct viewing field. The rotation angle of eyeball is set to be ±20° as wearing spectacles, and the field of view is set to be ±7° which is especially important as watching screen display. The individual eye model is constructed as the main part of the lens-eye system. The Liou eye model is modified by sticking a thin meniscus lens to the crystalline lens. Then the defocus of the individual eye is transferred to the front surface of the meniscus lens, and the astigmatism and high-order aberrations are transferred to the front surface of the cornea. 50 eyes are involved in this research, among which 36 eyes have good enough visual performance already after sphero-cylindrical correction. 10 eyes have distinct improvement in vision and 4 eyes have no visual improvement by further aspheric correction. 6 typical subject eyes are selected for the aberrations analysis and the spectacles design in this paper. It is shown that the validity of visual correction of aspheric lens depends on the characteristics of the eye's wavefront aberrations, and it is effective for the eye with larger astigmatism or spherical aberration. Compared with sphero-cylindrical correction only, the superiority taken by the aspheric correction is mainly on the improvement of MTF at a larger field of view. For the best aspheric correction, the MTF values increase by 18.87%, 38.34%, 44.36%, 51.29% and 57.32% at the spatial frequencies of 40, 80, 100, 125 and 150 cycles/mm, respectively.展开更多
基金Supported by an Internal Research of New Vision Inc.,Taipei,Taiwan
文摘AIM: To analyze the clinical factors influencing the human vision corrections via the changing of ocular components of human eye in various applications; and to analyze refractive state via a new effective axial length.METHODS: An effective eye model was introduced by the ocular components of human eye including refractive indexes, surface radius(r1, r2, R1, R2) and thickness(t, T) of the cornea and lens, the anterior chamber depth(S1) and the vitreous length(S2). Gaussian optics was used to calculate the change rate of refractive error per unit amount of ocular components of a human eye(the rate function M). A new criterion of myopia was presented via an effective axial length.RESULTS: For typical corneal and lens power of 42 and 21.9 diopters, the rate function Mj(j=1 to 6) were calculated for a 1% change of r1, r2, R1, R2, t, T(in diopters) M1=+0.485, M2=-0.063, M3=+0.053, M4=+0.091, M5=+0.012, and M6=-0.021 diopters. For 1.0 mm increase of S1 and S2, the rate functions were M7=+1.35, and M8=-2.67 diopter/mm, respectively. These rate functions were used to analyze the clinical outcomes in various applications including laser in situ keratomileusis surgery, corneal cross linking procedure, femtosecond laser surgery and scleral ablation for accommodation.CONCLUSION: Using Gaussian optics, analytic formulas are presented for the change of refractive power due to various ocular parameter changes. These formulas provide useful clinical guidance in refractive surgery and other related procedures.
文摘BACKGROUND Diabetes is a serious public health concern in China,with 30%of patients developing retinopathy,and diabetic macular edema(DME)having the biggest impact on vision.High blood glucose level can cause retinal cell hypoxia,thus promoting vascular endothelial growth factor(VEGF)formation and increasing vascular permeability,which induces DME.Moreover,cell hypoxia can accelerate the rate of apoptosis,which leads to the aging of patients.In severe cases,optic cell apoptosis or retinal fibrosis and permanent blindness may occur.AIM To investigate and compare the efficacy,mechanism,and differences between two anti-VEGF drugs(Compaq and ranibizumab)in DME patients.METHODS Ninety-six patients with DME who attended our hospital from April 2018 to February 2020 were included and randomly divided into two groups(Compaq group and ranibizumab group).The groups received vitreal cavity injections of 0.5 mg Compaq and 0.5 mg ranibizumab,respectively,once a month.The best corrected visual acuity(BCVA),intraocular pressure(IOP),macular retinal thickness(CMT),macular choroidal thickness(SFCT),foveal no perfusion area(FAZ),superficial capillary density,deep capillary density,treatment effect,and adverse reactions were compared before and after treatment and between the two groups.RESULTS Before treatment and 1-mo post-treatment,there was no statistically significant difference in the estimated BCVA in both groups(P>0.05).BCVA decreased in the Compaq group 3 mo after treatment,and the difference was statistically significant(P<0.05).Before treatment,and 1 mo and 3 mo post-treatment,there was no statistically significant difference in the estimated IOP in either group(P>0.05).Before treatment and 1-mo post-treatment,there was no statistically significant difference in the estimated CMT,SFCT,or FAZ in either group(P>0.05).CMT and SFCT values decreased in the Compaq group 3 mo post-treatment,and the difference was statistically significant(P<0.05).Before treatment,and 1 mo and 3 mo post-treatment,there were no statistically significant differences in vascular density in the shallow or deep capillary plexi of the fovea,parafovea,or overall macular area between the two groups(P>0.05).Marked efficient,effective,and invalid rates were 70.83%and 52.08%,27.08%and 39.58%,and 2.08%and 8.33%in the Compaq and ranibizumab groups,respectively.The differences between the two groups were statistically significant(P<0.05).CONCLUSION Anti-VEGF drugs can effectively improve CMT and SFCT,without affecting microcirculation,thus providing an effective and safe treatment for patients with DME.
基金supported by the National Nature Science Foundation of China (Grant Nos. 60978068, 11104149)the Science and Technology Project of Tianjin City (Grant No. 10ZCKFGX18800)
文摘Aiming at the correction of high-order aberrations of human eye with spectacles, a design method of aspheric spectacles is proposed based on the eye's wavefront aberrations data. Regarding the eyeball and the spectacles as a whole system-the lens-eye system-the surface profiles of the spectacles are achieved by optimization procedure of lens design. Different from the conventional optometry, in which the refraction prescription is acquired with a visual chart, the design takes into account the two aspects of actual human viewing, eyeball rolling and certain distinct viewing field. The rotation angle of eyeball is set to be ±20° as wearing spectacles, and the field of view is set to be ±7° which is especially important as watching screen display. The individual eye model is constructed as the main part of the lens-eye system. The Liou eye model is modified by sticking a thin meniscus lens to the crystalline lens. Then the defocus of the individual eye is transferred to the front surface of the meniscus lens, and the astigmatism and high-order aberrations are transferred to the front surface of the cornea. 50 eyes are involved in this research, among which 36 eyes have good enough visual performance already after sphero-cylindrical correction. 10 eyes have distinct improvement in vision and 4 eyes have no visual improvement by further aspheric correction. 6 typical subject eyes are selected for the aberrations analysis and the spectacles design in this paper. It is shown that the validity of visual correction of aspheric lens depends on the characteristics of the eye's wavefront aberrations, and it is effective for the eye with larger astigmatism or spherical aberration. Compared with sphero-cylindrical correction only, the superiority taken by the aspheric correction is mainly on the improvement of MTF at a larger field of view. For the best aspheric correction, the MTF values increase by 18.87%, 38.34%, 44.36%, 51.29% and 57.32% at the spatial frequencies of 40, 80, 100, 125 and 150 cycles/mm, respectively.